Stay updated with breaking news from Mark Sumeray. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
93% of patients in Cohort 2 discontinued both active vitamin D and oral calcium supplementation, while maintaining mean serum calcium within the target range Mean 24-hour urinary calcium was rapidly
Data from cohort 2 and full Phase 2a clinical trial to be presented at the 38th Congress of the French Society of Endocrinology and 2022 International HypoPARAthyroidism ConferenceLYON, France and CAMBRIDGE
KOL event to follow company's presentation at the American Society for Bone and Mineral Research (ASBMR) 2022 Annual MeetingLYON, France and CAMBRIDGE, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Amolyt
Investegate announcements from Amolyt Pharma, Amolyt Pharma to Host Hybrid Key Opinion Leader Event on its Potential Hypoparathyroidism Treatment, AZP-3601, on Monday, September 12th at 1:30pm CT/2:30pm ET in Austin, Texas
KOL event to follow company’s presentation at the American Society for Bone and Mineral Research (ASBMR) 2022 Annual Meeting...